316 related articles for article (PubMed ID: 27149125)
1. Serum Visfatin, Adiponectin, and Tumor Necrosis Factor Alpha (TNF-α) Levels in Patients with Psoriasis and their Correlation with Disease Severity.
Sereflican B; Goksugur N; Bugdayci G; Polat M; Haydar Parlak A
Acta Dermatovenerol Croat; 2016 Apr; 24(1):13-9. PubMed ID: 27149125
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-α inhibitors: results of a retrospective analysis.
Campanati A; Ganzetti G; Giuliodori K; Marra M; Bonfigli A; Testa R; Offidani A
Int J Dermatol; 2015 Jul; 54(7):839-45. PubMed ID: 25877149
[TBL] [Abstract][Full Text] [Related]
3. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
Erten Y; Ebinç FA; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
Ren Fail; 2008; 30(6):617-23. PubMed ID: 18661412
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of visfatin, resistin and adiponectin in patients with psoriatic arthritis and associations with disease severity.
Dikbas O; Tosun M; Bes C; Tonuk SB; Aksehirli OY; Soy M
Int J Rheum Dis; 2016 Jul; 19(7):672-7. PubMed ID: 25196858
[TBL] [Abstract][Full Text] [Related]
5. The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo.
Li L; Yang G; Shi S; Yang M; Liu H; Boden G
Cytokine; 2009 Jan; 45(1):12-9. PubMed ID: 19026557
[TBL] [Abstract][Full Text] [Related]
6. Serum Visfatin, Fetuin-A, and Pentraxin 3 Levels in Patients With Psoriasis and Their Relation to Disease Severity.
Okan G; Baki AM; Yorulmaz E; Doğru-Abbasoğlu S; Vural P
J Clin Lab Anal; 2016 Jul; 30(4):284-9. PubMed ID: 25867925
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha alters visfatin and adiponectin levels in human fat.
Hector J; Schwarzloh B; Goehring J; Strate TG; Hess UF; Deuretzbacher G; Hansen-Algenstaedt N; Beil FU; Algenstaedt P
Horm Metab Res; 2007 Apr; 39(4):250-5. PubMed ID: 17447161
[TBL] [Abstract][Full Text] [Related]
8. Assessment of visfatin concentrations in the serum of male psoriatic patients in relation to metabolic abnormalities.
Chyl-Surdacka KM; Bartosińska J; Kowal M; Przepiórka-Kosińska J; Krasowska D; Chodorowska G
Adv Clin Exp Med; 2020 Jan; 29(1):79-84. PubMed ID: 32017476
[TBL] [Abstract][Full Text] [Related]
9. Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.
Genc H; Dogru T; Kara M; Tapan S; Ercin CN; Acikel C; Karslioglu Y; Bagci S
Ann Hepatol; 2013; 12(4):548-55. PubMed ID: 23813132
[TBL] [Abstract][Full Text] [Related]
10. Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
Cantarini L; Obici L; Simonini G; Cimaz R; Bacarelli MR; Merlini G; Vitale A; Lucherini OM; Brizi MG; Galeazzi M; Fioravanti A
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S108-14. PubMed ID: 22935190
[TBL] [Abstract][Full Text] [Related]
11. Increased levels and adipose tissue expression of visfatin in morbidly obese women: the relationship with pro-inflammatory cytokines.
Terra X; Auguet T; Quesada I; Aguilar C; Luna AM; Hernández M; Sabench F; Porras JA; Martínez S; Lucas A; Pellitero S; Llutart J; del Castillo D; Richart C
Clin Endocrinol (Oxf); 2012 Nov; 77(5):691-8. PubMed ID: 22182404
[TBL] [Abstract][Full Text] [Related]
12. Serum and skin levels of miR-369-3p in patients with psoriasis and their correlation with disease severity.
Guo S; Zhang W; Wei C; Wang L; Zhu G; Shi Q; Li S; Ge R; Li K; Gao L; Gao T; Wang G; Li C
Eur J Dermatol; 2013; 23(5):608-13. PubMed ID: 24135466
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of visfatin and omentin-1 in patients with psoriasis and their relation to disease severity.
Ismail SA; Mohamed SA
Br J Dermatol; 2012 Aug; 167(2):436-9. PubMed ID: 22486212
[TBL] [Abstract][Full Text] [Related]
14. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.
Auguet T; Terra X; Porras JA; Orellana-Gavaldà JM; Martinez S; Aguilar C; Lucas A; Pellitero S; Hernández M; Del Castillo D; Richart C
Clin Biochem; 2013 Feb; 46(3):202-8. PubMed ID: 23174488
[TBL] [Abstract][Full Text] [Related]
15. Visfatin, low-grade inflammation and body mass index (BMI).
Samara A; Pfister M; Marie B; Visvikis-Siest S
Clin Endocrinol (Oxf); 2008 Oct; 69(4):568-74. PubMed ID: 18248642
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Adipokines, Inflammatory Markers, and Sex Hormones in Simple and Complex Breast Cysts' Fluid.
Madej P; Franik G; Kurpas P; Owczarek A; Chudek J; Olszanecka-Glinianowicz M
Dis Markers; 2016; 2016():5174929. PubMed ID: 27293305
[TBL] [Abstract][Full Text] [Related]
17. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
[TBL] [Abstract][Full Text] [Related]
18. Visfatin, TNF-alpha and IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women.
Tsiotra PC; Tsigos C; Yfanti E; Anastasiou E; Vikentiou M; Psarra K; Papasteriades C; Raptis SA
Horm Metab Res; 2007 Oct; 39(10):758-63. PubMed ID: 17952840
[TBL] [Abstract][Full Text] [Related]
19. Plasma visfatin and tumor necrosis factor-alpha (TNF-α) levels in metabolic syndrome.
Olszanecka-Glinianowicz M; Kocełak P; Janowska J; Skorupa A; Nylec M; Zahorska-Markiewicz B
Kardiol Pol; 2011; 69(8):802-7. PubMed ID: 21850623
[TBL] [Abstract][Full Text] [Related]
20. Leptin, adiponectin, visfatin and retinol-binding protein-4 - mediators of comorbidities in patients with psoriasis?
Gerdes S; Osadtschy S; Rostami-Yazdi M; Buhles N; Weichenthal M; Mrowietz U
Exp Dermatol; 2012 Jan; 21(1):43-7. PubMed ID: 22151390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
